CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 81 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $141,000 | -2.1% | 9,533 | -7.3% | 0.00% | 0.0% |
| Q2 2017 | $144,000 | -18.2% | 10,289 | 0.0% | 0.00% | -25.0% |
| Q1 2017 | $176,000 | +100.0% | 10,289 | +19.6% | 0.00% | +100.0% |
| Q4 2016 | $88,000 | +1.1% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $87,000 | -10.3% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $97,000 | -17.1% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $117,000 | -28.2% | 8,600 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $163,000 | +1.2% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $161,000 | +25.8% | 8,600 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $128,000 | +80.3% | 8,600 | +84.5% | 0.00% | +50.0% |
| Q1 2015 | $71,000 | – | 4,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |